Immungenetics AG
Quick facts
Marketed products
- TEP · Oncology
TEP is a therapeutic vaccine that works by stimulating the immune system to produce antibodies against the Epstein-Barr virus.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Immungenetics AG
What are Immungenetics AG's marketed drugs?
Top marketed products include TEP.
Related
- TEP · Oncology
- Sector hub: All tracked pharma companies